Hanson DC - Search Results

1

CP-123,369: a potent, orally active immunosuppressive agent.

Koch K, Hanson DC, Newborg MF, Cooper K, Fouda HG, Biehl ML, Shepard RM, Donovan CB, Biggers MS, Ramchandani M, et al. Koch K, et al. Among authors: hanson dc. Inflamm Res. 1995 Aug;44 Suppl 2:S183-4. doi: 10.1007/BF01778322. Inflamm Res. 1995. PMID: 8548388 No abstract available.

2

The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressant.

Koch K, Newborg MF, Hanson DC, Cooper K, Shepard RM, Biehl ML, Biggers MS, Ramchandani M, Schulte G, Snyder JR, et al. Koch K, et al. Among authors: hanson dc. J Med Chem. 1995 Apr 14;38(8):1255-8. doi: 10.1021/jm00008a001. J Med Chem. 1995. PMID: 7537331 No abstract available.

3

Ion channel modulation as a drug discovery target in inflammatory diseases.

Hanson DC, Koch K. Hanson DC, et al. Inflamm Res. 1996 Sep;45(9):435-7. doi: 10.1007/BF02252312. Inflamm Res. 1996. PMID: 8891752 No abstract available.

4

UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Hanson DC, Nguyen A, Mather RJ, Rauer H, Koch K, Burgess LE, Rizzi JP, Donovan CB, Bruns MJ, Canniff PC, Cunningham AC, Verdries KA, Mena E, Kath JC, Gutman GA, Cahalan MD, Grissmer S, Chandy KG. Hanson DC, et al. Br J Pharmacol. 1999 Apr;126(8):1707-16. doi: 10.1038/sj.bjp.0702480. Br J Pharmacol. 1999. PMID: 10372812 Free PMC article.

5

Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.

Nguyen A, Kath JC, Hanson DC, Biggers MS, Canniff PC, Donovan CB, Mather RJ, Bruns MJ, Rauer H, Aiyar J, Lepple-Wienhues A, Gutman GA, Grissmer S, Cahalan MD, Chandy KG. Nguyen A, et al. Among authors: hanson dc. Mol Pharmacol. 1996 Dec;50(6):1672-9. Mol Pharmacol. 1996. PMID: 8967992

6

Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis.

Otterness IG, Bliven ML, Downs JT, Natoli EJ, Hanson DC. Otterness IG, et al. Among authors: hanson dc. Cytokine. 1991 Jul;3(4):277-83. doi: 10.1016/1043-4666(91)90495-y. Cytokine. 1991. PMID: 1873477

7

The pharmacologic regulation of interleukin-1 production: the role of prostaglandins.

Otterness IG, Bliven ML, Eskra JD, Reinke M, Hanson DC. Otterness IG, et al. Among authors: hanson dc. Cell Immunol. 1988 Jul;114(2):385-97. doi: 10.1016/0008-8749(88)90330-9. Cell Immunol. 1988. PMID: 2968844

8

Possible role of IL-1 in arthritis: effects of prostaglandins in the regulation of IL-1 synthesis and actions.

Otterness IG, Hanson DC, Bliven ML. Otterness IG, et al. Among authors: hanson dc. Agents Actions Suppl. 1993;39:109-20. doi: 10.1007/978-3-0348-7442-7_12. Agents Actions Suppl. 1993. PMID: 8456622 Review. No abstract available.

9

Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.

Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, Karmilowicz MJ, Auperin DD, Chandy KG. Grissmer S, et al. Among authors: hanson dc. Mol Pharmacol. 1994 Jun;45(6):1227-34. Mol Pharmacol. 1994. PMID: 7517498

10

Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins.

Aiyar J, Withka JM, Rizzi JP, Singleton DH, Andrews GC, Lin W, Boyd J, Hanson DC, Simon M, Dethlefs B, et al. Aiyar J, et al. Among authors: hanson dc. Neuron. 1995 Nov;15(5):1169-81. doi: 10.1016/0896-6273(95)90104-3. Neuron. 1995. PMID: 7576659 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters